• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多酸的放射增敏平台,通过减轻放射抗性和增强辐射反应来治疗缺氧肿瘤。

Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.

机构信息

CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, Institute of High Energy Physics and National Center for Nanoscience Technology of China, Chinese Academy of Sciences , Beijing 100049, People's Republic of China.

College of Chemistry and Environment Protection Engineering, Southwest Minzu University , Chengdu 610041, People's Republic of China.

出版信息

ACS Nano. 2017 Jul 25;11(7):7164-7176. doi: 10.1021/acsnano.7b03037. Epub 2017 Jun 26.

DOI:10.1021/acsnano.7b03037
PMID:28640996
Abstract

Radioresistance is one of the undesirable impediments in hypoxic tumors, which sharply diminishes the therapeutic effectiveness of radiotherapy and eventually results in the failure of their treatments. An attractive strategy for attenuating radioresistance is developing an ideal radiosensitization system with appreciable radiosensitization capacity to attenuate tumor hypoxia and reinforce radiotherapy response in hypoxic tumors. Therefore, we describe the development of Gd-containing polyoxometalates-conjugated chitosan (GdW@CS nanosphere) as a radiosensitization system for simultaneous extrinsic and intrinsic radiosensitization, by generating an overabundance of cytotoxic reactive oxygen species (ROS) using high-energy X-ray stimulation and mediating the hypoxia-inducible factor-1a (HIF-1a) siRNA to down-regulate HIF-1α expression and suppress broken double-stranded DNA self-healing. Most importantly, the GdW@CS nanospheres have the capacity to promote the exhaustion of intracellular glutathione (reduced GSH) by synergy W-triggered GSH oxidation for sufficient ROS generation, thereby facilitating the therapeutic efficiency of radiotherapy. As a result, the as-synthesized GdW@CS nanosphere can overcome radioresistance of hypoxic tumors through a simultaneous extrinsic and intrinsic strategy to improve radiosensitivity. We have demonstrated GdW@CS nanospheres with special radiosensitization behavior, which provides a versatile approach to solve the critical radioresistance issue of hypoxic tumors.

摘要

放射抵抗性是缺氧肿瘤中一种不理想的障碍,它大大降低了放射治疗的疗效,最终导致治疗失败。减轻放射抵抗性的一种有吸引力的策略是开发一种具有可观放射增敏能力的理想放射增敏系统,以减轻肿瘤缺氧并增强缺氧肿瘤的放射治疗反应。因此,我们描述了一种含 Gd 的多金属氧酸盐-接枝壳聚糖(GdW@CS 纳米球)作为放射增敏系统的发展,通过使用高能 X 射线刺激产生过多的细胞毒性活性氧(ROS),并介导缺氧诱导因子-1a(HIF-1a)siRNA 下调 HIF-1α表达并抑制断裂的双链 DNA 自我修复,从而实现外源性和内源性放射增敏。最重要的是,GdW@CS 纳米球通过协同 W 触发的 GSH 氧化来促进细胞内谷胱甘肽(还原型 GSH)的耗竭,以产生足够的 ROS,从而提高放射治疗的疗效。因此,所合成的 GdW@CS 纳米球可以通过同时的外源性和内源性策略克服缺氧肿瘤的放射抵抗性,从而提高放射敏感性。我们已经证明了具有特殊放射增敏行为的 GdW@CS 纳米球,为解决缺氧肿瘤的关键放射抵抗性问题提供了一种通用的方法。

相似文献

1
Polyoxometalate-Based Radiosensitization Platform for Treating Hypoxic Tumors by Attenuating Radioresistance and Enhancing Radiation Response.基于多酸的放射增敏平台,通过减轻放射抗性和增强辐射反应来治疗缺氧肿瘤。
ACS Nano. 2017 Jul 25;11(7):7164-7176. doi: 10.1021/acsnano.7b03037. Epub 2017 Jun 26.
2
A GdW@PDA-CAT Sensitizer with High-Z Effect and Self-Supplied Oxygen for Hypoxic-Tumor Radiotherapy.一种具有高 Z 效应和自供氧的 GdW@PDA-CAT 敏化剂,用于缺氧肿瘤放射治疗。
Molecules. 2021 Dec 26;27(1):128. doi: 10.3390/molecules27010128.
3
Overcoming Radioresistance in Tumor Therapy by Alleviating Hypoxia and Using the HIF-1 Inhibitor.通过减轻缺氧和使用 HIF-1 抑制剂克服肿瘤治疗中的放射抵抗性。
ACS Appl Mater Interfaces. 2020 Jan 29;12(4):4231-4240. doi: 10.1021/acsami.9b18633. Epub 2020 Jan 17.
4
Sustained radiosensitization of hypoxic glioma cells after oxygen pretreatment in an animal model of glioblastoma and in vitro models of tumor hypoxia.在胶质母细胞瘤动物模型和肿瘤缺氧体外模型中,氧预处理后缺氧胶质瘤细胞的持续放射增敏作用。
PLoS One. 2014 Oct 28;9(10):e111199. doi: 10.1371/journal.pone.0111199. eCollection 2014.
5
Tumor microenvironment-manipulated radiocatalytic sensitizer based on bismuth heteropolytungstate for radiotherapy enhancement.基于铋杂多钨酸盐的肿瘤微环境调控放射敏化剂用于放疗增强。
Biomaterials. 2019 Jan;189:11-22. doi: 10.1016/j.biomaterials.2018.10.016. Epub 2018 Oct 15.
6
BiWO Semiconductor Nanoplates for Tumor Radiosensitization through High- Z Effects and Radiocatalysis.BiWO 半导体纳米板通过高 Z 效应和放射催化增强肿瘤放射敏感性。
ACS Appl Mater Interfaces. 2019 May 29;11(21):18942-18952. doi: 10.1021/acsami.9b03636. Epub 2019 May 15.
7
Hypoxic tumor cell radiosensitization: role of the iNOS/NO pathway.缺氧肿瘤细胞的放射增敏作用:诱导型一氧化氮合酶/一氧化氮途径的作用
Bull Cancer. 2008 Mar;95(3):282-91. doi: 10.1684/bdc.2008.0592.
8
Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression.齐墩果酸通过降低细胞内谷胱甘肽(GSH)含量和缺氧诱导因子-1α(HIF-1α)表达,增强模拟缺氧条件下肿瘤细胞的放射敏感性。
Oncol Rep. 2014 May;31(5):2399-406. doi: 10.3892/or.2014.3064. Epub 2014 Mar 6.
9
KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways.KNK437 通过双重靶向 AKT 和 HIF-1α 生存通路来消除缺氧诱导的放射抵抗。
Biochem Biophys Res Commun. 2012 May 11;421(3):538-43. doi: 10.1016/j.bbrc.2012.04.040. Epub 2012 Apr 13.
10
NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.NADPH 氧化酶亚基 4 介导循环缺氧促进多形性胶质母细胞瘤的放射抵抗。
Free Radic Biol Med. 2012 Aug 15;53(4):649-58. doi: 10.1016/j.freeradbiomed.2012.06.009. Epub 2012 Jun 16.

引用本文的文献

1
Chemical vs Physical Radioenhancement from TiO and Au Nanoparticles to Overcome Hypoxic Radioresistance in X-ray Therapy.二氧化钛和金纳米颗粒的化学与物理放射增强作用以克服X射线治疗中的缺氧放射抗性
Nano Lett. 2025 Aug 27;25(34):12806-12815. doi: 10.1021/acs.nanolett.5c02080. Epub 2025 Aug 14.
2
Biochemical hallmarks-targeting antineoplastic nanotherapeutics.靶向生物化学标志物的抗肿瘤纳米疗法
Bioact Mater. 2024 Jul 2;36:427-454. doi: 10.1016/j.bioactmat.2024.05.042. eCollection 2024 Jun.
3
Zinc-Modified Titanate Nanotubes as Radiosensitizers for Glioblastoma: Enhancing Radiotherapy Efficacy and Monte Carlo Simulations.
锌改性钛酸盐纳米管作为胶质母细胞瘤的放射增敏剂:提高放疗疗效及蒙特卡罗模拟
ACS Omega. 2024 Jun 28;9(27):29499-29515. doi: 10.1021/acsomega.4c02125. eCollection 2024 Jul 9.
4
Application of Multifunctional Nanozymes in Tumor Therapy.多功能纳米酶在肿瘤治疗中的应用。
ACS Omega. 2024 Mar 26;9(14):15753-15767. doi: 10.1021/acsomega.4c00258. eCollection 2024 Apr 9.
5
FeO@TiO Microspheres: Harnessing O Release and ROS Generation for Combination CDT/PDT/PTT/Chemotherapy in Tumours.FeO@TiO微球:利用氧释放和活性氧生成实现肿瘤中的联合光热疗法/光动力疗法/化学动力学疗法/化疗
Nanomaterials (Basel). 2024 Mar 10;14(6):498. doi: 10.3390/nano14060498.
6
Engineering the glioblastoma microenvironment with bioactive nanoparticles for effective immunotherapy.利用生物活性纳米颗粒构建胶质母细胞瘤微环境以实现有效的免疫治疗。
RSC Adv. 2023 Oct 27;13(45):31411-31425. doi: 10.1039/d3ra01153d. eCollection 2023 Oct 26.
7
Regulating electron transportation by tungsten oxide nanocapacitors for enhanced radiation therapy.通过氧化钨纳米电容器调节电子输运以增强放射治疗。
J Nanobiotechnology. 2023 Jun 29;21(1):205. doi: 10.1186/s12951-023-01962-8.
8
Low-temperature plasma-activated medium enhances the chemosensitivity of colorectal cancer cells by improving hypoxia.低温等离子体激活培养基通过改善缺氧增强结肠癌细胞的化学敏感性。
Am J Cancer Res. 2023 May 15;13(5):1985-1998. eCollection 2023.
9
Application of nano-radiosensitizers in combination cancer therapy.纳米放射增敏剂在联合癌症治疗中的应用。
Bioeng Transl Med. 2023 Feb 10;8(3):e10498. doi: 10.1002/btm2.10498. eCollection 2023 May.
10
Role of pyroptosis in the pathogenesis and treatment of diseases.细胞焦亡在疾病发病机制及治疗中的作用
MedComm (2020). 2023 Apr 25;4(3):e249. doi: 10.1002/mco2.249. eCollection 2023 Jun.